You just read:

Neumentum Announces Dosing of Patients in Phase I Study Evaluating Its Lead Product Candidate, NTM-001, a Non-Opioid in Development for the Management of Moderately Severe Acute Pain

News provided by

Neumentum

Sep 06, 2018, 09:30 ET